XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segments (Tables)
6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
Schedule of Consolidated Segment and Reconciliation
Financial data for the segments and reconciliation to consolidated results are:
PJMOtherCorporate and EliminationsTotal
Three Months Ended June 30, 2024 (Successor)
Operating revenues$438 $58 $(7)$489 
Interest expense— — 62 62 
Capital expenditures14 — — 14 
Adjusted EBITDA95 100 
May 18 through June 30, 2023 (Successor)
Operating revenues$355 $(30)$(24)$301 
Interest expense— — 33 33 
Capital expenditures23 10 34 
Adjusted EBITDA72 21 93 
April 1 through May 17, 2023 (Predecessor)
Operating revenues$78 $81 $(22)$137 
Interest expense— — 59 59 
Capital expenditures38 19 — 57 
Adjusted EBITDA44 47 
PJMOtherCorporate and EliminationsTotal
Six Months Ended June 30, 2024 (Successor)
Operating revenues$871 $208 $(81)$998 
Interest expense— — 121 121 
Capital expenditures66 14 — 80 
Adjusted EBITDA375 43 418 
May 18 through June 30, 2023 (Successor)
Operating revenues
$355 $(30)$(24)$301 
Interest expense— — 33 33 
Capital expenditures23 10 34 
Adjusted EBITDA
72 21 93 
January 1 through May 17, 2023 (Predecessor)
Operating revenues$1,054 $193 $(37)$1,210 
Interest expense— — 163 163 
Capital expenditures132 53 187 
Adjusted EBITDA688 37 725 
SuccessorPredecessorSuccessorPredecessor
Three Months Ended June 30, 2024May 18 through June 30, 2023April 1 through May 17, 2023Six Months Ended June 30, 2024May 18 through June 30, 2023January 1 through May 17, 2023
Adjusted EBITDA:
PJM$95 $72 $44 $375 $72 $688 
Other21 43 21 37 
Total Adjusted EBITDA$100 $93 $47 $418 $93 $725 
Reconciling Items:
Interest expense and other finance charges(62)(33)(59)(121)(33)(163)
Income tax benefit (expense)(112)(19)(198)(181)(19)(212)
Depreciation, amortization and accretion(75)(28)(68)(150)(28)(200)
Nuclear fuel amortization(28)(25)(9)(63)(25)(33)
Reorganization gain (loss), net— — 838 — — 799 
Unrealized (gain) loss on commodity derivative contracts91 41 (94)(44)41 (63)
Nuclear decommissioning trust funds gain (loss), net27 39 11 102 39 57 
Stock-based compensation expense(8)(16)— (16)(16)— 
Long-term incentive compensation expense(6)— — (16)— — 
Gain (loss) on asset sales, net561 — 15 885 — 50 
Non-cash impairments— — (16)— — (381)
Operational and other restructuring activities(19)(12)(9)(21)(12)(17)
Development expenses— (2)(3)— (2)(10)
Non-cash inventory net realizable value, obsolescence, and other charges(2)(3)(32)(3)(3)(56)
Noncontrolling interest18 14 
Other items(3)(1)11 (15)
Corporate and Eliminations(13)(14)(12)(42)(14)(30)
Net Income (Loss)$458 $31 $419 $777 $31 $465